REDHILL BIOPHARMA LTD. (RDHL) Net margin 2015–2024
REDHILL BIOPHARMA LTD. (RDHL) net profit margin by fiscal year — reported net income divided by reported revenue.
-102.8%FY2024 · since FY2015: -703000.0% → -102.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -102.8% | -469.0 pp |
| FY2023 | 366.2% | +482.2 pp |
| FY2022 | -116.0% | -2.0 pp |
| FY2021 | -114.0% | +4.4 pp |
| FY2020 | -118.4% | +554.1 pp |
| FY2019 | -672.5% | -208.1 pp |
| FY2018 | -464.4% | +672.3 pp |
| FY2017 | -1136.6% | +27942.6 pp |
| FY2016 | -29079.2% | +673920.8 pp |
| FY2015 | -703000.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More RDHL financial trends
RDHL RevenueRDHL Net incomeRDHL Gross profitRDHL Gross marginRDHL Operating incomeRDHL Operating marginRDHL Operating cash flowRDHL Free cash flowRDHL Capital expendituresRDHL Return on equityRDHL Stock buybacksRDHL Dividends paidRDHL Total assetsRDHL Total liabilitiesRDHL Shareholders’ equityRDHL overview →